BAY-155 structure
|
Common Name | BAY-155 | ||
|---|---|---|---|---|
| CAS Number | 2163769-52-4 | Molecular Weight | 567.635 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C28H28F3N7Os | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of BAY-155BAY-155 (BAY155) is a novel, potent and selective menin-MLL inhibitor with binding IC50 of 8 nM, 10-fold better compared to that of MI-503;BAY-155 demonstrated a significantly enhanced selectivity profile compared to MI-503 in a panel of assays covering numerous safety pharmacology-relevant targets including GPCRs, ion channels and transporters.BAY-155 shows anti-proliferative activity in a large cell line panel, exhibits specific therapeutic activityin AML/ALL models. |
| Name | BAY-155 |
|---|
| Description | BAY-155 (BAY155) is a novel, potent and selective menin-MLL inhibitor with binding IC50 of 8 nM, 10-fold better compared to that of MI-503;BAY-155 demonstrated a significantly enhanced selectivity profile compared to MI-503 in a panel of assays covering numerous safety pharmacology-relevant targets including GPCRs, ion channels and transporters.BAY-155 shows anti-proliferative activity in a large cell line panel, exhibits specific therapeutic activityin AML/ALL models. |
|---|---|
| References | 1. Krzysztof Brzezinka, et al. Cancers (Basel). 2020 Jan 14;12(1):201. |
| Molecular Formula | C28H28F3N7Os |
|---|---|
| Molecular Weight | 567.635 |